Status:
COMPLETED
Retrospective Survey of Safety of Fourth Dose Pentacel® in Children
Lead Sponsor:
Sanofi Pasteur, a Sanofi Company
Conditions:
Diphtheria
Pertussis
Eligibility:
All Genders
12-24 years
Brief Summary
The purpose of this survey is to collect selected safety data. Primary Objective: To collect selected safety data at 6 months following the 4th dose of the Pentacel® series.
Detailed Description
This is a retrospective survey to collect selected safety data at 6 months following the 4th dose of Pentacel® in children residing in the Canadian Province of British Columbia who have received the 4...
Eligibility Criteria
Inclusion
- Children residing in the Canadian Province of British Columbia who have received the 4th dose of the Pentacel® series before their 2nd birthday.
- Written Informed Consent and Telephone consent from the parent(s) or guardian(s).
- Able to comply with the survey procedures.
Exclusion
- Fourth dose of the Pentacel® series received on or after the child's 2nd birthday.
Key Trial Info
Start Date :
September 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2005
Estimated Enrollment :
3214 Patients enrolled
Trial Details
Trial ID
NCT00772369
Start Date
September 1 2003
End Date
April 1 2005
Last Update
February 14 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vancouver, British Columbia, Canada, V5Z 4R4